NKH477
Product Specifications
UNSPSC Description
NKH477 (Colforsin dapropate hydrochloride) directly activates the catalytic unit of adenylate cyclase and increases intracellular cAMP. NKH477 is a forskolin derivative that improves cardiac failure mainly through its beneficial effects on diastolic cardiac function. NKH477 exerts an antiproliferative effect in vivo with an altered cytokine profile to inhibit the acute rejection of rat orthotopic lung allografts[1].
Target Antigen
Adenylate Cyclase
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/nkh477.html
Purity
99.86
Solubility
DMSO : 100 mg/mL (ultrasonic)|H2O : 20 mg/mL (ultrasonic)
Smiles
O[C@@]12[C@@]3([C@@](C(C)(CC[C@@H]3O)C)([H])[C@H](OC(CCN(C)C)=O)[C@H](OC(C)=O)[C@]1(O[C@](C=C)(C)CC2=O)C)C.Cl
Molecular Weight
546.09
References & Citations
[1]Nakashima S, et al. Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts. J Heart Lung Transplant. 2005 Apr;24(4):462-9.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-103193/NKH477-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-103193/NKH477-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
138605-00-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2097313-01 0.01 mg
Active Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14)
Ask
View Details MBS2097313-02 0.05 mg
Active Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14)
Ask
View Details MBS2097313-03 0.1 mg
Active Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14)
Ask
View Details MBS2097313-04 0.2 mg
Active Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14)
Ask
View Details